Katie B Biello1,2,3,4, Matthew J Mimiaga5,6,7,8, Pablo K Valente9,10, Nimish Saxena5, Angela R Bazzi11,12. 1. Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA. katie_biello@brown.edu. 2. Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA. katie_biello@brown.edu. 3. Center for Health Promotion and Health Equity, Brown University, Providence, RI, USA. katie_biello@brown.edu. 4. The Fenway Institute, Fenway Health, Boston, MA, USA. katie_biello@brown.edu. 5. The Fenway Institute, Fenway Health, Boston, MA, USA. 6. Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA. 7. Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. 8. Center for LGBTQ Advocacy, Research, and Health, University of California Los Angeles, Los Angeles, CA, USA. 9. Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA. 10. Center for Health Promotion and Health Equity, Brown University, Providence, RI, USA. 11. Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA. 12. Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, San Diego, CA, USA.
Abstract
PURPOSE OF REVIEW: Recent HIV outbreaks among people who use drugs (PWUD) necessitate additional HIV prevention tools. Pre-exposure prophylaxis (PrEP) is highly efficacious yet uptake among PWUD remains exceedingly low. To address multilevel, complex barriers to PrEP use among PWUD, a range of intervention strategies are needed. RECENT FINDINGS: The literature on interventions to optimize PrEP use among PWUD is nascent, comprising small pilots and demonstration projects in early phases of intervention development. Initial studies suggest that structural, healthcare, interpersonal, and individual-level interventions can improve PrEP use for PWUD, and a number of efficacy trials are underway. Future studies are needed to optimize the use of new PrEP modalities (e.g., injectable PrEP), simultaneously target multilevel challenges to PrEP use, and evaluate the integration of PrEP into other service settings and substance use treatment modalities.
PURPOSE OF REVIEW: Recent HIV outbreaks among people who use drugs (PWUD) necessitate additional HIV prevention tools. Pre-exposure prophylaxis (PrEP) is highly efficacious yet uptake among PWUD remains exceedingly low. To address multilevel, complex barriers to PrEP use among PWUD, a range of intervention strategies are needed. RECENT FINDINGS: The literature on interventions to optimize PrEP use among PWUD is nascent, comprising small pilots and demonstration projects in early phases of intervention development. Initial studies suggest that structural, healthcare, interpersonal, and individual-level interventions can improve PrEP use for PWUD, and a number of efficacy trials are underway. Future studies are needed to optimize the use of new PrEP modalities (e.g., injectable PrEP), simultaneously target multilevel challenges to PrEP use, and evaluate the integration of PrEP into other service settings and substance use treatment modalities.
Authors: Stephen E Lankenau; Michelle Teti; Karol Silva; Jennifer Jackson Bloom; Alex Harocopos; Meghan Treese Journal: Int J Drug Policy Date: 2011-06-20
Authors: Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve Journal: MMWR Morb Mortal Wkly Rep Date: 2015-05-01 Impact factor: 17.586
Authors: Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-10 Impact factor: 17.586
Authors: Angela R Bazzi; Chad J Valasek; Samantha A Streuli; Carlos F Vera; Alicia Harvey-Vera; Morgan M Philbin; Katie B Biello; Alexis M Roth; Steffanie A Strathdee; Heather A Pines Journal: AIDS Patient Care STDS Date: 2022-06-21 Impact factor: 5.944
Authors: Katie B Biello; Pablo K Valente; Willey Y Lin; William Lodge Ii; Ryan Drab; Lisa Hightow-Weidman; Daniel Teixeira da Silva; Kenneth Mayer; José A Bauermeister Journal: AIDS Behav Date: 2021-12-03
Authors: Sena Sayood; Laura R Marks; Rupa Patel; Nathanial S Nolan; Stephen Y Liang; Michael J Durkin Journal: Open Forum Infect Dis Date: 2021-11-10 Impact factor: 3.835
Authors: Adrian R King; Saanchi Shah; Laura A Randall; Paula M Frew; Anne Spaulding; Ian W Holloway Journal: BMC Infect Dis Date: 2022-09-14 Impact factor: 3.667